Atlas Trials

Q Therapeutics, Inc.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Q Therapeutics, Inc.

RecordFirmDate
Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS) (NCT02478450)Q Therapeutics, Inc.2026-12-01
Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis (NCT03887273)Q Therapeutics, Inc.2022-09-20

Track Q Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.